Common Contracts
7 similar Underwriting Agreement contracts by Five Oaks Investment Corp., Foamix Pharmaceuticals Ltd., Microbot Medical Inc., others
MICROBOT MEDICAL INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2019 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Microbot Medical Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein (the “Agreement”), to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom H.C. Wainwright & Co., LLC, is acting as representative (the “Representative”), an aggregate of (a) [●] shares of common stock (the “Common Stock”), par value $0.01 per share, of the Company (the “Firm Shares”) and (b) pre-funded warrants (the “Pre-Funded Warrants” and, collectively with the Firm Shares, the “Firm Securities”) to purchase up to an aggregate of [●] shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrant Shares”) The Firm Shares and the Pre-Funded Warrants are referred to herein as the “Firm Securities.” The respective amounts of the Firm Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Compan
FOAMIX PHARMACEUTICALS LTD. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 2018 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products • New York
Foamix Pharmaceuticals Ltd., a company organized under the laws of the State of Israel (the “Company”) proposes to sell an aggregate of 11,670,000 of the Company’s ordinary shares (the “Firm Shares”), par value NIS 0.16 per share (the “Ordinary Shares”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 1,750,500 additional Ordinary Shares on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares”. This Agreement is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
4,000,000 Shares Five Oaks Investment Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 16th, 2017 • Five Oaks Investment Corp. • Real estate investment trusts • New York
Five Oaks Investment Corp., a Maryland corporation (the “Company”), proposes to sell 4,000,000 shares (the “Underwritten Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule 1 attached to this agreement (this “Agreement”) an option to purchase up to 600,000 additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Underwritten Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” This is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
SemGroup Corporation 7,500,000 of Class A Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 21st, 2016 • SemGroup Corp • Oil & gas field services, nec • New York
SemGroup Corporation, a Delaware corporation (the “Company”), proposes to sell to Barclays Capital Inc. (the “Underwriter”) 7,500,000 shares (the “Firm Shares”) of the Company’s Class A Common Stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant the Underwriter an option to purchase up to 1,125,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This Agreement is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriter.
4,500,000 Shares RING ENERGY, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 23rd, 2015 • Ring Energy, Inc. • Crude petroleum & natural gas • New York
Ring Energy, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions of this Underwriting Agreement (this “Agreement”), to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”), 4,500,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to 675,000 additional shares of Common Stock on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are hereinafter collectively called the “Shares.”
FOAMIX PHARMACEUTICALS LTD. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • April 10th, 2015 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products • New York
Cowen and Company, LLC Guggenheim Securities, LLC As Representatives of the several Underwriters named in Schedule I attached hereto,
3,500,000 Shares Five Oaks Investment Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 20th, 2014 • Five Oaks Investment Corp. • Real estate investment trusts • New York
